New 2021 Category III CPT Codes for Allogenic Disc Matrix…
- Home
- Public Policy
- Policy Statements
- New 2021 Category III CPT Codes for Allogenic Disc Matrix Material
- Categories
- Tags
New 2021 Category III CPT Codes for Allogenic Disc Matrix Material
On January 1, 2021, three new Current Procedural Terminology (CPT) codes for reporting the injection of allogenic disc matrix material went into effect. The three new CPT codes are:
0627T Percutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, unilateral or bilateral injection, with fluoroscopic guidance, lumbar; first level 0628T Percutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, unilateral or bilateral injection, with fluoroscopic guidance, lumbar; each additional level (List separately in addition to code for primary procedure) 0629T Percutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, unilateral or bilateral injection, with CT guidance, lumbar; each additional level (List separately in addition to code for primary procedure) ISASS sponsored and developed the code change proposal through the CPT Editorial Panel with Dr. James Yue, ISASS CPT Advisor, and Dr. Morgan Lorio, ISASS CPT Alternate Advisor, presenting the recommended code descriptors.
Because the new codes are Category III, no relative value units are set for the procedures, and providers are expected to provide estimated costs to payers for reimbursement. ISASS encourages physicians performing the service to determine their practice costs for the service and bill accordingly with the Category III code(s).